A new clinical study has provided evidence for the safety and effectiveness of a natural product that reduces foreign DNA that comes from an HPV infection. - CBCD
Rochester, NY (PRWEB) August 28, 2013
The mission of the CBCD is to advance research on the biology of foreign DNA. The HPV virus is known as a “DNA Virus.” Thus, the CBCD is excited that a new clinical study has provided evidence for the safety and effectiveness of a natural product that reduces foreign DNA that comes from an HPV infection (1). Also, the Center believes that the product is the only treatment capable of decreasing the concentration of latent HPV in infected individuals. The study was published in the peer reviewed, scientific journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs.
This paper is unique because it reports a clinical study on a proprietary, patent protected, natural formula in a peer reviewed, medical journal.
The study is important since it corresponds with another study published in April of 2012 in the Journal of General Virology, which said that currently, “There are no antiviral drugs for the treatment of HPV infection and disease (2).”
“Current treatments (against HPV) include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission (1).”
In addition, Cancer.gov says on its website concerning the two available HPV vaccines that they do not treat HPV in individuals already infected with the virus (3). Moreover, WebMD said, in a page last reviewed by Dr. Kimball Johnson, MD on August 13, 2012, that “These HPV vaccines are not foolproof. They do not protect against all of the 100-plus types of HPV (4).”
Further, the Gardasil website itself notes that “GARDASIL may not fully protect everyone, nor will it protect against diseases caused by other HPV types… GARDASIL does not prevent all types of cervical cancer… GARDASIL does not treat cervical cancer or genital warts (5).”
In contrast, Gene-Eden-VIR was shown to reduce HPV symptoms in individuals already infected with HPV. Study authors wrote that, “individuals infected with the HPV, …reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (1).” The study authors also wrote that “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (1).”
Since the CBCD believes in Dr. Polansky’s theory that identifies latent viruses as the cause of most major diseases, the Center sees Gene-Eden-VIR as an important first step towards curing a latent HPV infection.
To view the entire paper,
We invite the media to contact us for interviews at: info(at)buy-gene-eden(dot)com or phone 585-250-9999.
The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.